A detailed history of Russell Investments Group, Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 118,244 shares of DXCM stock, worth $8.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
118,244
Previous 126,919 6.84%
Holding current value
$8.97 Million
Previous $14.4 Million 44.93%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $555,200 - $1.01 Million
-8,675 Reduced 6.84%
118,244 $7.92 Million
Q2 2024

Aug 08, 2024

BUY
$110.31 - $140.45 $3.01 Million - $3.83 Million
27,298 Added 27.4%
126,919 $14.4 Million
Q1 2024

May 08, 2024

SELL
$114.22 - $140.1 $4.73 Million - $5.8 Million
-41,384 Reduced 29.35%
99,621 $13.8 Million
Q4 2023

Feb 05, 2024

SELL
$75.49 - $124.16 $577,649 - $950,072
-7,652 Reduced 5.15%
141,005 $17.5 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $2.34 Million - $3.75 Million
27,168 Added 22.36%
148,657 $13.9 Million
Q2 2023

Aug 10, 2023

SELL
$112.47 - $130.98 $4.88 Million - $5.68 Million
-43,368 Reduced 26.31%
121,489 $15.6 Million
Q1 2023

May 09, 2023

BUY
$104.0 - $122.92 $4.16 Million - $4.91 Million
39,982 Added 32.02%
164,857 $19.2 Million
Q4 2022

Feb 08, 2023

BUY
$84.98 - $122.67 $3.34 Million - $4.82 Million
39,295 Added 45.92%
124,875 $14.1 Million
Q3 2022

Nov 04, 2022

SELL
$76.35 - $94.18 $1.27 Million - $1.56 Million
-16,608 Reduced 16.25%
85,580 $6.96 Million
Q2 2022

Jul 29, 2022

BUY
$67.99 - $132.89 $4.74 Million - $9.26 Million
69,655 Added 214.11%
102,188 $7.65 Million
Q1 2022

May 05, 2022

SELL
$94.08 - $130.2 $4.65 Million - $6.44 Million
-49,449 Reduced 60.32%
32,533 $16.7 Million
Q4 2021

Jan 21, 2022

SELL
$129.87 - $162.82 $2.95 Million - $3.7 Million
-22,704 Reduced 21.69%
81,982 $44.1 Million
Q3 2021

Nov 08, 2021

SELL
$106.71 - $143.18 $526,613 - $706,593
-4,935 Reduced 4.5%
104,686 $57.2 Million
Q2 2021

Aug 04, 2021

SELL
$80.99 - $107.93 $536,963 - $715,575
-6,630 Reduced 5.7%
109,621 $46.8 Million
Q1 2021

May 10, 2021

SELL
$84.79 - $104.74 $2.63 Million - $3.25 Million
-31,008 Reduced 21.06%
116,251 $41.7 Million
Q4 2020

Feb 08, 2021

BUY
$78.0 - $104.5 $1.99 Million - $2.67 Million
25,525 Added 20.97%
147,259 $54.2 Million
Q3 2020

Nov 09, 2020

SELL
$95.51 - $112.95 $1.17 Million - $1.38 Million
-12,258 Reduced 9.15%
121,734 $50.1 Million
Q2 2020

Aug 05, 2020

SELL
$62.68 - $105.34 $2.64 Million - $4.43 Million
-42,055 Reduced 23.89%
133,992 $54.2 Million
Q1 2020

May 06, 2020

BUY
$47.79 - $75.63 $7.21 Million - $11.4 Million
150,902 Added 600.13%
176,047 $47.6 Million
Q4 2019

Jan 29, 2020

BUY
$36.62 - $57.29 $101,071 - $158,120
2,760 Added 12.33%
25,145 $5.47 Million
Q3 2019

Nov 01, 2019

BUY
$35.53 - $43.8 $41,747 - $51,465
1,175 Added 5.54%
22,385 $3.34 Million
Q2 2019

Aug 09, 2019

SELL
$27.84 - $38.92 $80,040 - $111,895
-2,875 Reduced 11.94%
21,210 $3.16 Million
Q1 2019

May 13, 2019

SELL
$28.07 - $38.18 $507,758 - $690,638
-18,089 Reduced 42.89%
24,085 $2.87 Million
Q4 2018

Feb 11, 2019

SELL
$26.99 - $37.37 $334,649 - $463,350
-12,399 Reduced 22.72%
42,174 $5.02 Million
Q3 2018

Oct 26, 2018

BUY
$23.35 - $36.72 $304,484 - $478,828
13,040 Added 31.4%
54,573 $7.81 Million
Q2 2018

Aug 08, 2018

SELL
$17.54 - $25.22 $858,337 - $1.23 Million
-48,936 Reduced 54.09%
41,533 $3.94 Million
Q1 2018

May 11, 2018

SELL
$13.06 - $18.54 $3.33 Million - $4.72 Million
-254,627 Reduced 73.78%
90,469 $6.71 Million
Q4 2017

Feb 06, 2018

BUY
$11.12 - $15.38 $123,632 - $170,994
11,118 Added 3.33%
345,096 $19.8 Million
Q3 2017

Nov 07, 2017

BUY
$11.36 - $18.98 $3.79 Million - $6.34 Million
333,978
333,978 $16.3 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.